HSSCX
Price
$20.75
Change
+$0.18 (+0.88%)
Updated
Apr 17 closing price
Net Assets
44.09M
PRISX
Price
$39.92
Change
+$0.18 (+0.45%)
Updated
Apr 17 closing price
Net Assets
1.71B
Ad is loading...

HSSCX vs PRISX

Header iconHSSCX vs PRISX Comparison
Open Charts HSSCX vs PRISXBanner chart's image
Emerald Finance & Bking Innovt Fd C
Price$20.75
Change+$0.18 (+0.88%)
VolumeN/A
Net Assets44.09M
T. Rowe Price Financial Services
Price$39.92
Change+$0.18 (+0.45%)
VolumeN/A
Net Assets1.71B
HSSCX vs PRISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HSSCX vs. PRISX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSSCX is a Buy and PRISX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PRISX has more cash in the bank: 1.71B vs. HSSCX (44.1M). HSSCX pays higher dividends than PRISX: HSSCX (2.41) vs PRISX (1.14). HSSCX was incepted earlier than PRISX: HSSCX (25 years) vs PRISX (29 years). HSSCX (2.43) is less costly to investors than PRISX (0.98). HSSCX is a more actively managed with annual turnover of: 56.00 vs. PRISX (46.90). HSSCX has a lower initial minimum investment than PRISX: HSSCX (2000) vs PRISX (2500). HSSCX annual gain was more profitable for investors over the last year : 19.63 vs. PRISX (8.54). PRISX return over 5 years is better than : 111.68 vs. HSSCX (31.06).
HSSCXPRISXHSSCX / PRISX
Total Expense Ratio2.430.93261%
Annual Report Gross Expense Ratio2.430.98248%
Fund Existence25 years29 years-
Gain YTD-9.223-5.606165%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets44.1M1.71B3%
Annual Yield % from dividends2.411.14212%
Returns for 1 year19.638.54230%
Returns for 3 years-25.9424.86-104%
Returns for 5 years31.06111.6828%
Returns for 10 years-11.8796.63-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHIX36.43N/A
N/A
Hartford Healthcare I
ICTEX13.37N/A
N/A
ICON Health and Information Tech Instl
DRLYX7.97N/A
N/A
BNY Mellon Developed Markets RE Scs - Y
FRISX83.49N/A
N/A
Franklin Rising Dividends R6
MSGFX31.25N/A
N/A
Morgan Stanley Inst Global Franchise C